FTC appeal is “demonstrably wrong”, says ViroPharma

Shire ViroPharma is calling for an appeals court to affirm a ruling against the Federal Trade Commission, on the grounds that the agency did not demonstrate the company is, or is about to, violate the law.

Get unlimited access to all Global Competition Review content